HPC · Science Deep Dive 18 June 2026 · revised 16 September 2026

Probiotics and Mental Health: What the Gut-Brain Axis Science Actually Shows.

The gut microbiome does more than influence digestion. It runs a parallel signalling network that shapes mood, stress response, and cognitive function, and the evidence that targeted probiotics can modulate depressive symptoms is now stronger than most people realise, and more nuanced than the supplement industry admits. Here is what the science actually says, and what to do with it.

Section: Nutrition · Gut-Brain
Reading time: 22 min read
Sources: 34 · reviewed

THE VERDICT, IN BRIEF
The evidence from 34 peer-reviewed sources, including five flagship studies ranked by methodological weight, establishes that the gut microbiome is a measurable, modifiable input to mood regulation, and that targeted probiotic intervention, when used as an augmentation of existing psychiatric treatment, produces clinically meaningful reductions in depressive symptoms. The effect sizes are real (SMD=−0.64 to −0.96 in clinical populations), the mechanism is biologically plausible across five converging pathways, and the neuroimaging data confirms that probiotic-driven signals reach the brain and change its activity. What the evidence does not support, and what the supplement industry frequently implies, is that probiotics are a standalone treatment for depression. They are not. They are a signal-layer addition to a system that needs every input it can get. Read the full verdict →

01The Psychobiotic Question

Serotonin is mostly made in the gut, not the brain

The most prescribed class of psychiatric medication in the Western world targets a molecule that the brain does not primarily manufacture. Roughly 90 percent of the body's serotonin (the neurotransmitter most commonly associated with mood regulation) is synthesised not in the cortex or the brainstem but in the lining of the gastrointestinal tract, by specialised enterochromaffin cells that sit among trillions of bacteria.^[5] That biochemical fact has been known for decades. What is new, and what changes the clinical picture, is the mounting evidence that those bacteria are not passive bystanders. They are active participants in the signalling chain that determines whether you feel anxious, resilient, or flat.

Depression now affects roughly five percent of the world's adult population, approximately 400 million people.^[2] Anxiety disorders run close behind at four percent.^[1] The standard pharmacological response targets monoamine pathways in the brain. But a parallel line of research, accelerating sharply since 2019, has been asking a different question: what if part of the problem originates lower, in the gut, and what if part of the solution does too?

The term for this idea is psychobiotics: live organisms that, when ingested in adequate amounts, produce a measurable benefit to mental health.^[3] Timothy Dinan and John Cryan at University College Cork coined it in 2013, and the field has since grown from a speculative hypothesis into a research programme with more than 50 clinical trials, multiple meta-analyses, and findings that are more promising than the supplement aisle suggests, and more complicated than popular coverage admits.^[18]

The history

The probiotics brain science literature has a clarity problem. Popular reporting tends to collapse all probiotic research into a single headline, "gut bacteria affect mood," which is both true and uselessly vague. Different strains produce different effects, different populations respond differently, and the finding that rarely makes it into wellness content is the most important one: probiotics appear to work as an augmentation of existing psychiatric treatment, not a replacement for it.^[14]

Nikolova and colleagues demonstrated this in 2021 with a meta-analysis of seven randomised controlled trials restricted to clinically depressed participants. Adjunctive probiotic treatment, added alongside antidepressants, produced a large effect (SMD=0.83). Stand-alone probiotics produced an effect of essentially zero (SMD=−0.02).^[14] That distinction is not a footnote. It is the central clinical finding of the field, and it reframes everything that follows.

The gut-brain axis is not a supplement story. It is a systems biology story involving the vagus nerve, the enteric nervous system, the immune cascade, and the hypothalamic-pituitary-adrenal axis. Understanding what probiotics actually do to mood requires understanding each of those channels. Understanding which probiotics matter requires a harder look at the evidence than most coverage has delivered.

02The Mechanism

The Five-Channel Highway Between Your Gut and Your Brain

The human gut contains between 200 and 600 million neurons, a network large enough that neuroscientists call it the enteric nervous system, or the second brain.^[1] That label is not poetic. The enteric nervous system can operate autonomously, generating its own reflexes and maintaining gut motility without any input from the central nervous system. But it does not operate in isolation. It is wired through the vagus nerve directly to the brainstem, and roughly 80 percent of the signals travelling along that nerve move in the gut-to-brain direction.^[34]

That asymmetry matters. The gut is not waiting for instructions from above. It is broadcasting. The content of that broadcast is shaped, in measurable ways, by the composition of the gut microbiome, the roughly 38 trillion microorganisms that colonise the gastrointestinal tract.^[1] When Bravo and colleagues at University College Cork severed the vagus nerve in mice receiving Lactobacillus rhamnosus, every behavioural and neurochemical benefit of the probiotic disappeared.^[6] The vagus nerve was not incidentally involved in the signalling. It was the signalling.

That finding is the sharpest mechanistic demonstration in the field. It was performed in mice, not humans, and a subsequent attempt to replicate the behavioural effects in healthy human males found no significant results, an important translational failure the field has been slow to fully reckon with.^[21] But the principle it established, that gut bacteria influence brain function through a specific anatomical pathway, has been supported by converging human evidence, including a 2023 study in Molecular Psychiatry confirming that vagal integrity is required for microbiome-driven depressive-like behaviours in animal models.^[11]

The gut-brain signalling cascade: microbiome bacteria generate SCFAs and neuroactive compounds, carried afferently through the vagus nerve (80% gut-to-brain), while butyrate crosses the blood-brain barrier to reshape prefrontal cortex activity in depression-relevant circuits.

Diagram · HPC

The neural pathway is the fastest but not the only channel. Gut bacteria also influence the brain through short-chain fatty acids, metabolic byproducts of fibre fermentation, principally butyrate, propionate, and acetate. Butyrate strengthens the intestinal barrier, modulates immune signalling, and crosses into the central nervous system where it influences gene expression in the hippocampus.^[7] Acetate contributes approximately 30 percent of the substrate for neuronal GABA synthesis, the brain's primary inhibitory neurotransmitter.^[7]

A second channel runs through the immune system. When the intestinal barrier loses integrity (a condition sometimes called leaky gut), bacterial fragments including lipopolysaccharide cross into the bloodstream and trigger systemic inflammation.^[25] Pro-inflammatory cytokines then cross the blood-brain barrier and activate microglia, the brain's resident immune cells, producing neuroinflammation that is consistently associated with major depressive disorder.^[22] A 2025 systematic review confirmed that leaky gut biomarkers predict depression severity and suicidal risk.^[24]

The third channel is endocrine. Gut bacteria modulate the HPA axis (the hypothalamic-pituitary-adrenal stress response system) through cortisol regulation and tryptophan metabolism. They also produce neurotransmitters directly: the gut manufactures approximately 90 percent of the body's serotonin, and specific bacterial genera synthesise dopamine, GABA, acetylcholine, and norepinephrine.^[5]^[12]

03Evidence

The Five Strongest Studies on Probiotics and Mental Health

01The claim

The single load-bearing finding

The hero study finds −0.96 SMD.

Ranking evidence is not a neutral act. It requires deciding what counts more: sample size or causal clarity, breadth of measurement or depth of mechanism, statistical significance or clinical significance. The five studies ranked below were selected from 34 peer-reviewed sources and ordered by a six-criterion rubric that weights design architecture, sample scope, methodological rigour, causal inference strength, independent replication, and field influence.^[13]^[8]^[14]^[15]^[9]

Pooled estimate

−0.96 SMD

02How we measured

Grading the psychobiotic trials

Studies scored on design, sample, rigour, causality, replication, citations.

Strain specificity and heterogeneity define the limits of probiotic evidence: effect sizes in meta-analyses span SMD -0.64 to -0.96 depending on population and strain, so study design and participant diagnosis are more predictive than supplement dose.

Rubric weights

Design/30

Sample/20

Rigour/15

Causality/15

Replication/10

Citations/10

03The spread

Heterogeneity across 5 studies

Methodological quality across the ranked studies.

The heterogeneity deserves direct confrontation. I² values in probiotic-depression meta-analyses reach as high as 96.29 percent.^[17] That number reflects a field where different teams use different strains, different doses, different durations, different outcome measures, and different populations, then pool the results as though they were studying the same intervention.

Rubric spread

→ 71 /100

Highest to lowest rubric score across the ranked studies.

04What does not hold

Negative knowledge

What the evidence base does not support.

The evidence supports, with increasing confidence, the biological plausibility of the entire pathway. Crocetta's 2024 systematic review found that all 11 randomised controlled trials using fMRI to assess probiotic effects on the brain reported changes in emotional processing circuits: amygdala, precuneus, orbitofrontal cortex, and insula.^[10] A comprehensive review of 51 psychobiotic studies across 3,353 participants found high efficacy specifically for depressive symptoms.^[18]

The studies

5 trials. One pooled answer.

Below: the anchor study in full; then the forest plot at scale; then the supporting trials in ranked order.

01Anchor

Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples

Asad Nutrition Reviews 2024 Meta-Analysis · Clinical Population · RCT-Derived

The clinical-population restriction is the key contribution. Most prior meta-analyses included healthy volunteers, which diluted effect estimates. When restricted to patients who actually have depression, the effects are substantially larger.

Largest N among clinical-only meta-analyses; RCT-derived; addresses the critical limitation of prior work by excluding subclinical samples.

Rubric breakdown

Design27/30

Sample18/20

Rigour10/15

Causality12/15

Replication8/10

Citations7/10

Total 82/100

The strongest studies, ranked by methodological weight.

Each scored 0–100 against a six-criterion rubric, tagged by design and year; the anchor leads. No study in this set reaches the rubric-90 tier.

Anchor (Rank 1) Supporting

Rank Authors & title Journal · Year Finding Score

Radjabzadeh

Gut Microbiome-Wide Association Study of Depressive Symptoms

Nature Communications · 2022

Identified 13 microbial taxa significantly associated with depressive symptoms across two independent ethnically diverse cohorts (N=2,593), including depleted Coprococcus, Subdoligranulum, and Ruminococcaceae, key producers of butyrate, serotonin, and GABA.^[8]

78/100

Nikolova

Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment

Journal of Clinical Medicine · 2021

Adjunctive probiotic treatment alongside antidepressants yielded a large effect (SMD=0.83) in clinically depressed participants. Stand-alone probiotic treatment showed no significant benefit (SMD=−0.02).^[14]

76/100

Schaub

Clinical, Gut Microbial and Neural Effects of a Probiotic Add-On Therapy in Depressed Patients

Translational Psychiatry · 2022

Probiotic add-on therapy produced a large between-group effect on HAM-D continuous scores at 8-week follow-up (d=0.95, t=2.95, p<.01). The end-of-treatment (31-day) effect was d=0.62, still clinically meaningful but smaller. The probiotic group showed putamen activation normalisation and maintained microbial diversity while the placebo group's declined.^[15]

73/100

Tillisch

Consumption of Fermented Milk Product With Probiotic Modulates Brain Activity

Gastroenterology · 2013

Four weeks of probiotic consumption produced 49% cross-block covariance (P=.004) in a widely distributed brain network. The probiotic group showed reduced amygdala and insula activation during emotional face processing, the same circuits implicated in depression and anxiety.^[9]

71/100

04Stakes

The cost of ignoring the gut-brain axis is not theoretical. It is measurable in clinical, cognitive, and immune outcomes.

Gut dysbiosis does not produce a single symptom. It degrades multiple systems simultaneously, and the consequences compound.

01 System 01

Mood & Affective Regulation

Dysbiosis in antidepressant-naive patients shows a distinct microbial signature compared to healthy controls: depleted butyrate producers, elevated pro-inflammatory genera.^[23] This pattern precedes pharmacological intervention, suggesting gut disruption is upstream of the diagnosis, not downstream of the treatment. A 2025 meta-analysis confirmed leaky gut biomarkers as predictors of depression severity.^[24]

In practice

persistent low mood, emotional flatness, reduced stress tolerance, anhedonia

02 System 02

Gastrointestinal-Psychiatric Loop

IBS patients carry a depression prevalence of 29 percent and anxiety prevalence of 39 percent, rates three to five times higher than general population baselines.^[26] A Korean claims-based analysis of 3.9 million individuals found IBS patients had double the odds of depression (OR=1.77).^[27] The relationship is bidirectional: gut dysfunction worsens mood, and mood dysfunction worsens gut symptoms.

In practice

bloating, irregular bowel habits, food sensitivities, anxiety about eating, social avoidance

System 03

Neuroinflammatory Cascade

When intestinal barrier integrity fails, lipopolysaccharide crosses into systemic circulation and triggers a pro-inflammatory cytokine response that reaches the brain.^[25] Chronic low-grade neuroinflammation is now considered a core pathway in treatment-resistant depression.^[22]

In practice

brain fog, fatigue disproportionate to exertion, slow recovery from illness, cognitive sluggishness

04 System 04

Stress Response Dysregulation

The HPA axis depends on microbial inputs for calibration. When Berding's psychobiotic diet trial measured perceived stress, the intervention group showed 32 percent reduction compared to 17 percent in controls.^[20] Gut microbiota from anxious individuals, transplanted into germ-free mice, reproduced the anxiety phenotype, demonstrating causal transmission of stress-related behaviour through microbial composition alone.^[28]

In practice

exaggerated startle response, difficulty winding down, cortisol-driven sleep disruption, chronic tension

05Protocol

A 4-Step Gut-Brain Optimisation Protocol

Evidence-informed, not evidence-mandated. These steps are supported by clinical trial data but do not constitute medical advice. They represent the strongest available science on modifiable gut-brain inputs.

The protocol, as a sequence.

Weeks 1–12 → Daily → Ongoing → Before starting

01 Step 01 · Weeks 1–12

Strain-Specific Supplementation

Take a multi-strain probiotic containing Lactobacillus and Bifidobacterium species at 10⁸–10¹¹ CFU/day for 4–12 weeks, alongside any existing treatment.

Why

Network meta-analysis identifies Bifidobacterium as highest-probability genus for anxiety reduction and the Lactobacillus-Bifidobacterium combination as optimal for depression.^[30] Strain-specific meta-analysis confirms significant BDI reductions for L. acidophilus, L. casei, L. plantarum, B. longum, and B. lactis.^[16] Mean effective intervention length across trials is 9.8 weeks.^[29]

Common mistake

Taking a random "probiotic blend" with no strain specificity. Consumer products rarely contain the studied strains at studied doses. The evidence is strain-specific, and generic products are not interchangeable with trial formulations.^[33]

02 Step 02 · Daily

Prebiotic Dietary Foundation

Prioritise a high-fibre, high-fermented-food dietary pattern: the psychobiotic diet.

Why

Freijy's "Gut Feelings" RCT (N=119) found the prebiotic diet arm produced significant mood improvement (d=−0.60) while the probiotic supplement arm alone did not.^[19] Berding's psychobiotic diet trial showed 32% stress reduction with microbial stability linked to outcomes.^[20] Diet provides the substrate; supplements provide the strains.

Common mistake

Relying on supplements alone without dietary change. The evidence for diet-based prebiotic intervention is actually stronger than for isolated probiotic supplementation in some trials.^[20]^[31]

03 Step 03 · Ongoing

Duration Calibration

Monitor response within a 4–12 week window and reassess if no benefit is observed.

Why

Zandifar's meta-analysis subgroup analysis found that interventions of 4–12 weeks were effective, while those exceeding 12 weeks showed diminished or lost effects.^[17] This suggests a colonisation plateau: the window for microbial establishment is finite.

Common mistake

Continuing indefinitely without assessment. If 12 weeks produce no measurable benefit, the current strain-dose combination is likely not the right one for the individual.^[18]^[32]

04 Step 04 · Before starting

Clinical Integration

Discuss psychobiotic supplementation with your prescriber as an adjunctive strategy, not a standalone treatment.

Why

Nikolova's meta-analysis is unambiguous: adjunctive use alongside antidepressants produces a large effect (SMD=0.83); standalone use produces no significant effect (SMD=−0.02).^[14] Schaub's triple-endpoint trial confirmed the adjunctive pattern with both neuroimaging and microbiome data.^[15]

Common mistake

Replacing prescribed medication with probiotics. This is the most dangerous misapplication of the evidence and is directly contradicted by the strongest available data.^[15]

Operational logic

The protocol is deliberately conservative. It does not promise transformation. It promises what the evidence supports: a measurable augmentation of existing treatment, operating through a biological pathway that conventional psychiatry has underweighted. The probiotics brain science literature does not support replacing antidepressants. It supports adding a second input, a microbial one, that modulates the same circuits through a different channel.^[33]

The operating principle is signal layering, not signal switching. Just as combination antibiotic therapy targets different bacterial vulnerabilities simultaneously, adjunctive psychobiotic therapy targets the gut-brain axis while pharmacotherapy targets central neurotransmitter systems. The two interventions are not competing. They are converging on the same downstream target, mood-relevant neural circuitry, from opposite ends of the axis.

That framing also explains why the evidence for dietary intervention is, in some trials, stronger than for supplementation alone. Berding's psychobiotic diet changes the microbial environment itself, providing fibre substrates that feed existing beneficial bacteria, while supplements introduce specific strains that may or may not establish in an inhospitable gut.^[20] The most defensible application of the evidence is both: dietary foundation plus targeted supplementation, calibrated to a finite intervention window and integrated with existing care.

06Verdict

The verdict.

"The question is no longer whether bacteria influence the brain. The question is which bacteria, through which pathways, at which doses.", Adapted from Valles-Colomer et al. (2019), Nature Microbiology

Bottom line

The gut does not ask permission to influence the brain. The only question is whether you manage that influence deliberately or let it run unattended.

The argument

The evidence from 34 peer-reviewed sources, including five flagship studies ranked by methodological weight, establishes that the gut microbiome is a measurable, modifiable input to mood regulation, and that targeted probiotic intervention, when used as an augmentation of existing psychiatric treatment, produces clinically meaningful reductions in depressive symptoms. The effect sizes are real (SMD=−0.64 to −0.96 in clinical populations), the mechanism is biologically plausible across five converging pathways, and the neuroimaging data confirms that probiotic-driven signals reach the brain and change its activity. What the evidence does not support, and what the supplement industry frequently implies, is that probiotics are a standalone treatment for depression. They are not. They are a signal-layer addition to a system that needs every input it can get.

The mistake most people make with the gut-brain axis is treating it as a supplement question. It is a systems biology question involving neural anatomy, microbial ecology, immune signalling, and endocrine regulation. The supplement is the delivery mechanism. The biology is the intervention.

That reframing matters because it changes what you optimise for. You do not optimise for the best probiotic brand. You optimise for the microbial environment that produces the right signals: dietary fibre for short-chain fatty acid production, fermented foods for bacterial diversity, specific strains for specific neurotransmitter pathways, and a clinical context that keeps the intervention honest about what it can and cannot do.

The field is young. The heterogeneity is real. The strain specificity problem has not been fully solved. But the direction of evidence, from population studies to mechanistic models to controlled clinical trials to neuroimaging confirmation, is more convergent than most areas of nutritional psychiatry. The gut-brain axis is not a hypothesis anymore. It is a target. The question has shifted from "Does it work?" to "How precisely can we make it work?"

The whole argument, on one axis

Same pill. Opposite outcome.

01Claim

Measurable Modulation

The gut microbiome shapes mood through five converging biological pathways. Thirteen specific taxa are depleted in depression, and restoring them through probiotic and dietary intervention changes brain activation patterns in the circuits that regulate emotion.^[8]^[10]

02Consequence

Augmentation, Not Replacement

Probiotics produce large effects when combined with antidepressant treatment (SMD=0.83) and no significant effect when used alone (SMD=−0.02).^[14] Ignoring this distinction is the most common and most dangerous misapplication of the gut-brain science.

03Lever

Strain-Specific, Time-Limited

The actionable lever is a targeted, 4–12 week probiotic and dietary protocol integrated with clinical care. Generic products at untested doses for indefinite durations are not supported by the evidence. Strain specificity and duration calibration matter.^[16]^[17]

Put it to work

Where this science goes next on HPC

AssessmentGut Brain AssessmentScore where you actually stand Protocol90-Day Metabolic ResetTurn the mechanism into practice GlossaryGut-Brain AxisThe definition, held to the evidence

07Bibliography

The bibliography.

34 sources · ~5h est. corpus read · 34 visible

RCT · 2 Meta · 8 Review · 3 Journal · 21

Type

Sort

01 Journal

Ansari, F., Neshat, M., Pourjafar, H., Jafari, S. M., Samakkhah, S. A., & Mirzakhani, E2023

The role of probiotics and prebiotics in modulating of the gut-brain axis

Frontiers in Nutrition

doi: 10.3389/fnut.2023.1173660
a b c
02 Journal

World Health Organization2023

World Mental Health Report: Transforming mental health for all

WHO

no doi
↩
03 Journal

Dinan, T. G., Stanton, C., & Cryan, J. F2013

Psychobiotics: A novel class of psychotropic

Biological Psychiatry74(10) · 720–726

doi: 10.1016/j.biopsych.2013.05.001
↩
04 Journal

Lewandowska-Pietruszka, Z., Figlerowicz, M., & Mazur-Melewska, K.2022

The History of the Intestinal Microbiota and the Gut-Brain Axis

11(12), 154011(12)

doi: 10.3390/pathogens11121540
↩
05 Review

Akram, M., et al2024

Exploring the serotonin-probiotics-gut health axis: A review of current evidence and potential mechanisms

Food Science & Nutrition12(3) · 1–14

doi: 10.1002/fsn3.3826
a b
06 Journal

Bravo, J. A., Forsythe, P., Chew, M. V., et al2011

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

PNAS108(38) · 6050–1605

doi: 10.1073/pnas.1102999108
↩
07 Journal

Wang, D., et al.2025

From bugs to brain: Unravelling the GABA signalling networks in the brain-gut-microbiome axis

148(5), 1479148(5)

doi: 10.1093/brain/awae388
a b
08 Journal

Rubric 78/100

Radjabzadeh, D., Bosch, J. A., Uitterlinden, A. G., et al2022

Gut microbiome-wide association study of depressive symptoms

Nature Communications

doi: 10.1038/s41467-022-34502-3
a b c
09 Journal

Rubric 71/100

Tillisch, K., Labus, J., Kilpatrick, L., et al2013

Consumption of fermented milk product with probiotic modulates brain activity

Gastroenterology144(7) · 1394–1401

doi: 10.1053/j.gastro.2013.02.043
a b
10 Meta

Crocetta, T., Liloia, D., Costa, T., et al2024

From gut to brain: Unveiling probiotic effects through a neuroimaging perspective, A systematic review of randomized controlled trials

Frontiers in Nutrition

doi: 10.3389/fnut.2024.1446854
a b
11 Journal

Siopi, E., et al.2023

Gut microbiota changes require vagus nerve integrity to promote depressive-like behaviors in mice

doi: 10.1038/s41380-023-02071-6
↩
12 Journal

Author not identified in source2021

Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders

Retrieved from

source
↩
13 Meta

Asad, A., Kirk, M., Zhu, S., Dong, X., & Gao, M2024

Effects of prebiotics and probiotics on symptoms of depression and anxiety in clinically diagnosed samples: Systematic review and meta-analysis of randomized controlled trials

Nutrition Reviews83(7)

doi: 10.1093/nutrit/nuae177
↩
14 Meta

Rubric 76/100

Nikolova, V. L., Cleare, A. J., Young, A. H., & Stone, J. M2021

Updated review and meta-analysis of probiotics for the treatment of clinical depression: Adjunctive vs. stand-alone treatment

Journal of Clinical Medicine10(4)

doi: 10.3390/jcm10040647
a b c d e f
15 RCT

Rubric 73/100

Schaub, A.-C., Schneider, E., Vazquez-Castellanos, J. F., et al2022

Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: A randomized controlled trial

Translational Psychiatry

doi: 10.1038/s41398-022-01977-z
a b c d
16 Meta

Rahmannia, M., Mohammadpour, S., Sanaie, S., et al2024

Strain-specific effects of probiotics on depression and anxiety: A meta-analysis

Gut Pathogens

doi: 10.1186/s13099-024-00634-8
a b
17 Meta

Zandifar, A., Badrfam, R., & Salehi, M2025

The effect of prebiotics and probiotics on levels of depression, anxiety, and cognitive function: A meta-analysis of randomized clinical trials

Brain and Behavior15(3)

doi: 10.1002/brb3.70401
a b c
18 Meta

Mosquera, F. E. C., Lizcano Martinez, S., & Liscano, Y.2024

Effectiveness of Psychobiotics in the Treatment of Psychiatric and Cognitive Disorders: A Systematic Review of Randomized Clinical Trials

16(9), 135216(9)

doi: 10.3390/nu16091352
a b c
19 RCT

Freijy, T., et al2022

Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The "Gut Feelings" randomised controlled trial

Frontiers in Neuroscience

doi: 10.3389/fnins.2022.1097278
↩
20 Journal

Berding, K., Bastiaanssen, T. F. S., Moloney, G. M., et al2022

Feed your microbes to deal with stress: A psychobiotic diet impacts microbial stability and perceived stress in a healthy adult population

Molecular Psychiatry601–610

doi: 10.1038/s41380-022-01817-y
a b c d
21 Journal

Kelly, J. R., Allen, A. P., Temko, A., et al2017

Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects

Brain, Behavior, and Immunity50–59

doi: 10.1016/j.bbi.2016.11.018
↩
22 Journal

Author not identified in source2023

Gut microbiota in anxiety and depression: Unveiling the relationships and management options

Retrieved from

source
a b
23 Journal

Lin, S. K. K., et al.2025

Dysbiosis and depression: A study of gut microbiota alterations and functional pathways in antidepressant-naïve mood disorder patients

doi: 10.1038/s41398-025-03521-1
↩
24 Meta

Morena, D., Lippi, M., Scopetti, M., Turillazzi, E., & Fineschi, V.2025

Leaky Gut Biomarkers as Predictors of Depression and Suicidal Risk: A Systematic Review and Meta-Analysis

15(13), 168315(13)

doi: 10.3390/diagnostics15131683
a b
25 Journal

Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P.2015

Breaking Down the Barriers: The Gut Microbiome, Intestinal Permeability and Stress-related Psychiatric Disorders

9, 392

doi: 10.3389/fncel.2015.00392
a b
26 Journal

Aziz, M., Kumar, J., Muhammad Nawawi, K., Raja Ali, R., & Mokhtar, N.2021

Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain

13(9), 306113(9)

doi: 10.3390/nu13093061
↩
27 Journal

Kim, Y., et al.2025

Depression Among Individuals with Irritable Bowel Syndrome: A Nationwide Claims-Based Analysis of 3.9 Million Koreans

13(23), 299813(23)

doi: 10.3390/healthcare13232998
↩
28 Journal

Ritz, N. L., et al.2023

Social anxiety disorder-associated gut microbiota increases social fear

120(42), e2308706120120(42)

doi: 10.1073/pnas.2308706120
↩
29 Review

Kazlausky Esquivel, M.2022

Probiotics for Mental Health: A Review of Recent Clinical Trials

doi: 10.1177/15598276211049178
↩
30 Journal

Wong, S. M. Y., et al.2022

Assessment of optimal combinations of therapeutic probiotics for depression, anxiety, and stress

(Cambridge)

doi: 10.1017/S0033291722001519
↩
31 Meta

Huang, R., & Liu, Y.2024

Efficacy of Bifidobacterium-related preparations on depression: The first meta-analysis

15, 1463848

doi: 10.3389/fpsyt.2024.1463848
↩
32 Journal

Slykerman, R. F., Davies, N., & Donohoe, R2025

Evaluating the scientific evidence to support mental health and well-being claims made on probiotic products

SAGE Journals

doi: 10.1177/02601060241305682
↩
33 Journal

Mörkl, S., Butler, M. I., Holl, A., Cryan, J. F., & Dinan, T. G.2020

Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry

doi: 10.1007/s13668-020-00313-5
a b
34 Review

The Microbiota-Gut-Brain Axis2019

Physiological Reviews

99(4), 1877–201399(4) · 1877–2013

doi: 10.1152/physrev.00018.2018
↩

The protocol card